NL-OMON53144招募中不适用
ptake and biodistribution of 89Zirconium-labeled ipilimumab in ipilimumab treated patients with metastatic melanoma - Tumor uptake of 89Zirconium-ipilumumab
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 22
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational invasive
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Metastasized melanoma or unresectable malignant melanoma
- •- Scheduled for treatment with nivolumab and ipilimumab
- •- Age > 18 years
- •- At least one measurable lesion
- •- WHO performance status 0 or 1
排除标准
- •- Previous exposure to ipilimumab
- •- Pregnant or breast feeding women
- •- Concurrent anticancer chemotherapy, immunotherapy or investigational drug
- •during the study or within 4 weeks after starting study drug
- •- Radiotherapy on target lesions during the study or within 4 weeks after
- •starting study drug
研究者
相似试验
进行中（未招募）
1 期
ptake of 89Zr-labeled ipilimumab measured with PET-scan in patients who are treated with ipilimumabMedDRA version: 21.1Level: PTClassification code 10025671Term: Malignant melanoma stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: PTClassification code 10025670Term: Malignant melanoma stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Advanced melanomaEUCTR2012-003616-31-NLVU medical center24
尚未招募
不适用
Opname en biodistributie van 89Zirconium gelabeld ipilimumab in melanoompatiënten die behandeld worden met ipilimumabNL-OMON27886VU University Medical Center29
已完成
不适用
A Phase I Study to Assess Biodistribution of 89Zr-CB307 in PSMA+ and PSMA-Tumour LesionsNL-OMON51775Cresendo Biologics Ltd12
招募中
1 期
Safety, tolerability, and biodistribution of [89Zr]Zr-DFO-APAC (Phase 0) in subjects with peripheral arterial occlusive disease / critical limb ischemia (PAOD/CLI) and healthy volunteers – an open label PET study (CHASE-study)Critical limb ischemia, Peripheral arterial occlusive diseaseMedDRA version: 21.1Level: LLTClassification code: 10058072Term: Critical limb ischaemia Class: 10047065MedDRA version: 21.1Level: PTClassification code: 10062585Term: Peripheral arterial occlusive disease Class: 100000004866CTIS2023-505287-11-01Aplagon Oy10
终止
1 期
Immuno-positron Emission Tomography Study of 89Zr-S095012 in Patients With Advanced Solid TumoursAdvanced Solid TumorNCT05638334Institut de Recherches Internationales Servier3